Early program for parents of babies with rare genetic developmental disorders
Tests a parent coaching program for infants under one with rare neurogenetic disorders.
Key facts
- Who runs it
- RTI International
- Where
- Research Triangle Park, United StatesSee the site
- Trial code
- Registry title
- Parent and Infant Inter(X)Action Intervention (PIXI)
- Status
- Enrolling by invitation
- People taking part
- 120 people, planned
- Started
- 30 Nov 2018
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional
- Treatments tested
- Parent-Infant Inter(X)action Intervention (PIXI)
- Record updated
- 13 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for infants 15 months old or younger with a confirmed neurogenetic disorder, together with their parents or caregivers. English must be the main language at home.
- Age
- Infants 15 months of age or younger.
- Sex
- All sexes can join.
- Disease stage
- A confirmed diagnosis of a neurogenetic disorder, such as fragile X, Angelman, Prader-Willi, Dup15q, Phelan-McDermid, Smith Magenis, Williams or Turner syndrome, or Duchenne muscular dystrophy.
- Biomarker or test result
- The diagnosis must not have been sought only because of parental concerns about the infant, for example it came from prenatal or newborn screening, or from testing after a family member was diagnosed.
Main reasons for not taking part
- Infants who are blind
- Infants with a severe hearing impairment
- Homes where English is not the main language
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Infants 15 months of age or younger who have received a diagnosis which was not sought solely due to parental concerns about the infant (e.g. diagnosis due to prenatal or newborn screening, cascade testing following diagnosis of a family member)
- English must be the primary language spoken in the home because all assessment measures and intervention protocol are in English
Who cannot take part
- Infants may not be blind or have a severe hearing impairment as the intervention and assessments are not appropriate for these children
Where in United States
- RTI InternationalResearch Triangle Park, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The objective is to develop and test, through an iterative process, an intervention to address and support the development of infants with a confirmed diagnosis of a neurogenetic disorder with associated developmental delays or intellectual and developmental disabilities. The proposed project will capitalize and expand upon existing empirically based interventions designed to improve outcomes for infants with suspected developmental delays.
Read full original descriptionShow less
Participants will be infants with a confirmed diagnosis of a neurogenetic disorder (e.g., fragile X, Angelman, Prader-Willi, Dup15q, Phelan-McDermid, Rhett, Smith Magenis, Williams, Turner, Kleinfelter, Down syndromes, Duchenne muscular dystrophy) within the first year of life and their parents/caregivers.
The intervention, called the Parent and Infant Inter(X)action Intervention (PIXI) is a comprehensive program inclusive of parent education about early infant development and the neurogenetic disorder for which they were diagnosed, direct parent coaching around parent-child interaction, and family/parent well-being support. The protocol includes repeated comprehensive assessments of family and child functioning, along with an examination of feasibility and acceptability of the program.
The group in the trial
- Infants with a rare neurogenetic condition and their parent/primary caregiver(s)Treatment being tested
PIXI
Treatment: Parent-Infant Inter(X)action Intervention (PIXI)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Piloting an Early Intervention Program for Infants With Rare Neurogenetic Disorders
- Plain-language title
- Early program for parents of babies with rare genetic developmental disordersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 13 July 2026